Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes

Eugene Tan and K. Sandy Pang
Drug Metabolism and Disposition March 2001, 29 (3) 335-346;
Eugene Tan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Sandy Pang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The metabolic activities and tissue binding of estrone (E1) and estrone sulfate (E1S) on futile cycling were examined. Desulfation of E1S in the 9000g supernatant fraction (S9) of periportal (PP) and perivenous (PV) rat hepatocytes were of similarV maxE1S→E1 (2.9 ± 1.0 and 2.4 ± 0.9 nmol/min/mg of S9 protein),K mE1S→E1 (30.4 ± 8.3 and 34.8 ± 6.6 μM), and desulfation intrinsic clearances (V maxE1S→E1 /K mE1S→E1 of 77 and 55 μl/min/106 cells). The intrinsic clearance towards E1 sulfation (1 μM) in cytosolic preparations of PV hepatocytes was 4 times that of PP hepatocytes (V maxE1→E1S /K mE1→E1S of 26.4 ± 9.5 versus 6.1 ± 2.2 μl/min/mg of cytosolic protein or 13 ± 5 versus 3.1 ± 1.1 μl/min/106cells). The observation was consistent with the immunolocalization of estrogen sulfotransferase (PV/PP ratio of 3.4 ± 1.1) but not hydroxysteroid sulfotransferase (PV/PP ratio of 0.29 ± 0.21) nor phenol sulfotransferase (PV/PP ratio of 1.13 ± 0.23). Upon incubation of E1S (1–125 μM) with hepatocytes (30 min), higher concentrations of E1S and E1 were observed within PP than in PV cells, and saturation was evident at the higher concentrations. Based on the in vitro metabolic and tissue binding parameters for E1S and E1 and the published zonal uptake clearances of E1S (116 μl/min/106 cells), fitting revealed that uptake of E1 (1484 and 1463 μl/min/106 cells) by PP and PV cells was rapid and similar, and E1 sulfation was the slowest step in futile cycling. The greater metabolism of E1 in PV region led to higher levels of E1 and E1S in PP hepatocytes, and the nonlinear uptake, binding, and vesicular accumulation of E1S resulted in differentt1/2 values for E1S and E1.

Footnotes

  • Send reprint requests to: Dr. K. Sandy Pang, Faculty of Pharmacy, University of Toronto, 19 Russell St., Toronto, Ontario, Canada M5S 2S2. E-mail: ks.pang{at}utoronto.ca

  • This work was supported by the Medical Research Council of Canada (MT-15657). E.T. was a recipient of the Natural Sciences and Engineering Research Council and Medical Research Council of Canada graduate fellowships.

  • Abbreviations used are::
    E1S
    estrone sulfate
    E1
    estrone
    E2
    estradiol
    E1G
    estrone glucuronide
    PP
    periportal
    PV
    perivenous
    PAGE
    polyacrylamide gel electrophoresis
    PAPS
    3′-phosphoadenosine 5′-phosphosulfate
    HPLC
    high-performance liquid chromatography
    S9
    9000g supernatant fraction
    rSULT1A1
    -2A1, and -1E1, rat liver phenol, hydroxysteroid, and estrogen sulfotransferase, respectively
    AUC
    area under the concentration-time curve
    ANOVA
    analysis of variance
    M
    metabolite
    [E1Sunbound]ec and [E1Sbound]ec
    unbound and bound concentration of extracellular E1S, respectively
    [E1Sunbound]c and [E1Sbound]c
    unbound and bound concentration of cellular E1S, respectively
    [Ptotal]c and [Ptotal]ec
    total protein concentration in cellular and extracellular medium, respectively
    Vc
    cellular volume
    Vec
    extracellular volume
    CL intE1S→E1
    desulfation intrinsic clearance of E1S
    CL intE1→E1S
    sulfation intrinsic clearance of E1
    CL intE1→M
    metabolic intrinsic clearance of E1 to metabolites M
    CL uptakeE1S
    transport clearance of E1S
    Pdiff
    bidirectional uptake clearance
    KD
    binding dissociation constant
    • Received August 31, 2000.
    • Accepted November 17, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

Log in using your username and password

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 29 (3)
Drug Metabolism and Disposition
Vol. 29, Issue 3
1 Mar 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
Citation Tools
Research ArticleArticle

Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes

Eugene Tan and K. Sandy Pang
Drug Metabolism and Disposition March 1, 2001, 29 (3) 335-346;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes

Eugene Tan and K. Sandy Pang
Drug Metabolism and Disposition March 1, 2001, 29 (3) 335-346;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Appendix
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • P450 Activities in Paired Liver and Small Intestinal Samples
  • Numerical Analysis of Time-Dependent Inhibition by MDMA
  • NRF2-Independent Regulation of DMEs by Cadmium and ITCs
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics